Anamorelin

Anamorelin is an orally active ghrelin receptor agonist that mimics ghrelin's appetite-stimulating and growth hormone-releasing effects. It is developed and approved in some regions for treating cancer-related anorexia-cachexia syndrome.

In the literature, Anamorelin appears most often in work focused on appetite control, growth hormone and weight loss. Studies in this area tend to look at mechanisms and observed effects in laboratory and preclinical settings rather than outcomes in people, so the picture is best read as a map of where researchers have been curious — not as evidence of any benefit.

Because it is catalogued here under powder peptides, Anamorelin also shows up in discussions of muscle preservation. Coverage across those topics varies widely in quality and depth, and much of it is early-stage. Reading the underlying research directly is the only way to judge how strong any particular finding is.